Wolfgang Wadsak

Prof. Wolfgang Wadsak

Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2007 in Biological Psychiatry
Verified
Journal Article
Closed access
RLRupert Lanzenberger
Rupert Lanzenberger
Markus MitterhauserMarkus Mitterhauser
Markus Mitterhauser
CSChristoph Spindelegger
Christoph Spindelegger
Wolfgang WadsakWolfgang Wadsak
Wolfgang Wadsak
NKNikolas Klein
Nikolas Klein
JTJohannes Tauscher
Johannes Tauscher

1 October 2012 in NeuroImage
Verified
Journal Article
Closed access
MSMarkus Savli
Markus Savli
ABAndreas Bauer
Andreas Bauer
Markus MitterhauserMarkus Mitterhauser
Markus Mitterhauser
YDYu-Shin Ding
Yu-Shin Ding
AHAndreas Hahn
Andreas Hahn
RLRupert Lanzenberger
Rupert Lanzenberger

23 July 2003 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
ABAlexander Becherer
Alexander Becherer
GKGeorgios Karanikas
Georgios Karanikas
MSMonica Szabó
Monica Szabó
GZGeorg Zettinig
Georg Zettinig
SASusanne Asenbaum
Susanne Asenbaum
KKKurt Kletter
Kurt Kletter

13 December 2018 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
BGBernhard Grubmueller
Bernhard Grubmueller
PBPascal A.T. Baltzer
Pascal A.T. Baltzer
SHSabrina Hartenbach
Sabrina Hartenbach
DDDavid D’aNdrea
David D’aNdrea
THThomas H. Helbich
Thomas H. Helbich
MHMarkus Hartenbach
Markus Hartenbach
Purpose: Primary staging of prostate cancer relies on modalities, which are limited. We evaluate simultaneous [68Ga]Ga-PSMA-11 PET (PSMA-PET)/MRI as a new diagnostic method for primary tumor–node–metastasis staging compared with histology and its impact on therapeutic decisions. Experimental Design: We investigated 122 patients with PSMA-PET/MRI prior to planned radical prostatectomy (RP). Primary endpoint was the accuracy of PSMA-PET/MRI in tumor staging as compared with staging-relevant histology. In addition, a multidisciplinary team reassessed the initial therapeutic approach to evaluate its impact on the therapeutic management. Results: PSMA-PET/MRI correctly identified prostate cancer in 119 of 122 patients (97.5%). Eighty-one patients were treated with RP and pelvic lymphadenectomy. The accuracy for T staging was 82.5% [95% confidence interval (CI), 73–90; P < 0.001], for T2 stage was 85% (95% CI, 71–94; P < 0.001), for T3a stage was 79% (95% CI, 43–85; P < 0.001), for T3b stage was 94% (95% CI, 73–100; P < 0.001), and for N1 stage was 93% (95% CI, 84–98; P < 0.001). PSMA-PET/MRI changed the therapeutic strategy in 28.7% of the patients with either the onset of systemic therapy/radiotherapy (n = 16) or active surveillance (n = 19). Conclusions: PSMA-PET/MRI can provide an accurate staging of newly diagnosed prostate cancer. In addition, treatment strategies were changed in almost a third of the patients due to the information of this hybrid imaging technique.

1 November 2012 in NeuroImage
Verified
Journal Article
Closed access
RLRupert Lanzenberger
Rupert Lanzenberger
GKGeorg S. Kranz
Georg S. Kranz
DHDaniela Haeusler
Daniela Haeusler
EAElena Akimova
Elena Akimova
MSMarkus Savli
Markus Savli
SKSiegfried Kasper
Siegfried Kasper

30 January 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
AHAndreas Hahn
Andreas Hahn
Wolfgang WadsakWolfgang Wadsak
Wolfgang Wadsak
Christian WindischbergerChristian Windischberger
Christian Windischberger
PBPia Baldinger
Pia Baldinger
AHAnna S. Höflich
Anna S. Höflich
RLRupert Lanzenberger
Rupert Lanzenberger
Reflecting one's mental self is a fundamental process for evaluating the personal relevance of life events and for moral decision making and future envisioning. Although the corresponding network has been receiving growing attention, the driving neurochemical mechanisms of the default mode network (DMN) remain unknown. Here we combined positron emission tomography and functional magnetic resonance imaging to investigate modulations of the DMN via serotonin-1A receptors (5-HT1A), separated for 5-HT autoinhibition (dorsal raphe nucleus) and local inhibition (heteroreceptors in projection areas). Using two independent approaches, regional 5-HT1Abinding consistently predicted DMN activity in the retrosplenial cortex for resting-state functional magnetic resonance imaging and the Tower of London task. On the other hand, both local and autoinhibitory 5-HT1Abinding inversely modulated the posterior cingulate cortex, the strongest hub in the resting human brain. In the frontal part of the DMN, a negative association was found between the dorsal medial prefrontal cortex and local 5-HT1Ainhibition. Our results indicate a modulation of key areas involved in self-referential processing by serotonergic neurotransmission, whereas variations in 5-HT1Abinding explained a considerable amount of the individual variability in the DMN. Moreover, the brain regions associated with distinct introspective functions seem to be specifically regulated by the different 5-HT1Abinding sites. Together with previously reported modulations of dopamine and GABA, this regional specialization suggests complex interactions of several neurotransmitters driving the default mode network.